gonadotrophin releasing hormone
gonadotrophin releasing hormone: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: CG Oncology, Inc. (CGON)
Development Pipeline (1)
| Company | Phase |
|---|---|
| CG Oncology, Inc. (CGON) | Phase 1/Phase 2 |
Clinical Trials (1)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Frequently asked questions
Who is developing gonadotrophin releasing hormone?
gonadotrophin releasing hormone is being developed by CG Oncology, Inc..
How many clinical trials involve gonadotrophin releasing hormone?
BioSniper tracks 1 clinical trial involving gonadotrophin releasing hormone.
Analyze CG Oncology, Inc. & gonadotrophin releasing hormone with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company